5% DEXTROSE SALINE

5% Dextrose Solution is a widely used intravenous infusion intended for fluid and caloric replacement in clinical settings. Manufactured by Dana Pharmaceuticals Limited in Nigeria, this solution is designed to meet the needs of patients who require parenteral hydration and a source of energy, especially when oral intake is not feasible.

Product Overview

Product Name: 5% Dextrose Solution for Infusion (500/1000 mL)

Active Ingredient: Anhydrous Dextrose (as Dextrose Monohydrate BP)

Concentration: 5% w/v

Dosage Form: Solution for infusion

Route of Administration: Intravenous (IV)

Pack Sizes: 500 mL and 1000 mL (Viaflo pouches)

ATC Code: B05BB02

Product Category: Drugs

Marketing Category: Prescription-only Medicine (POM)

Product Description: Intravenous Infusion

Regulatory and Manufacturing Information

Applicant Name: Dana Pharmaceuticals Limited

NRN: 04-0857

Status: Active

Approval Date: August 3, 2021

Manufacturer: Dana Pharmaceuticals Limited

Country of Manufacture: Nigeria

Composition

Each 100 mL of solution contains:

Dextrose Monohydrate BP: 5 g (w/v)

Water for Injection: Quantity sufficient to 100 mL

Clinical Uses

5% Dextrose Solution is commonly used for:

Fluid Replacement: Correction of dehydration in patients unable to ingest fluids orally.

Energy Supply: Provides a readily available source of carbohydrates (glucose) for metabolism.

Diluent: Used as a vehicle for the administration of other intravenous medications.

Product Description

The solution is supplied in sterile Viaflo pouches, available in both 500 mL and 1000 mL sizes. It is a clear, colorless liquid designed for direct intravenous administration, ensuring rapid absorption and reliable clinical outcomes.